What's Going On With Ampio Pharmaceuticals Stock?

Ampio Pharmaceuticals, Inc. AMPE shares are trading lower Friday after spiking more than 200% on Thursday. Here's a look at what's going on:

What To Know:

Shares of AMPE are falling on heavy trading volume Friday. According to data from Benzinga Pro, more than 738 thousand shares have been traded in the session, compared to the stock's 100-day average volume of less than 332 thousand shares. Ampio Pharmaceuticals' stock has a float of less than 815 thousand shares.

Ampio Pharmaceuticals Inc. is a biopharmaceutical company focused on the clinical development of Ampion which is in clinical trials and is being developed for the treatment of severe Osteoarthritis of the Knee, an intravenous treatment for COVID-19 patients, and an inhaled treatment for COVID-19-induced respiratory distress.

Related News: Meme Stocks Rally: To The Moon Or Failure To Launch?

AMPE Price Action: According to Benzinga Pro, Ampio Pharmaceuticals shares are down by 44% at $3.20 at the time of publication.

Image: PublicDomainPictures from Pixabay